MCID: CHL034
MIFTS: 9

Childhood Malignant Hemangiopericytoma

Categories: Cancer diseases

Aliases & Classifications for Childhood Malignant Hemangiopericytoma

MalaCards integrated aliases for Childhood Malignant Hemangiopericytoma:

Name: Childhood Malignant Hemangiopericytoma 12 73
Malignant Pediatric Hemangiopericytoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:7731
NCIt 50 C8090
UMLS 73 C0279983

Summaries for Childhood Malignant Hemangiopericytoma

MalaCards based summary : Childhood Malignant Hemangiopericytoma, is also known as malignant pediatric hemangiopericytoma. The drugs Mechlorethamine and Ifosfamide have been mentioned in the context of this disorder.

Related Diseases for Childhood Malignant Hemangiopericytoma

Symptoms & Phenotypes for Childhood Malignant Hemangiopericytoma

Drugs & Therapeutics for Childhood Malignant Hemangiopericytoma

Drugs for Childhood Malignant Hemangiopericytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 36)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Mechlorethamine Approved, Investigational Phase 3 51-75-2 4033
2
Ifosfamide Approved Phase 3,Phase 2 3778-73-2 3690
3
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
4
Carboplatin Approved Phase 3,Phase 2 41575-94-4 10339178 38904 498142
5
Dactinomycin Approved, Investigational Phase 3,Phase 2 50-76-0 457193 2019
6
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
7
Cyclophosphamide Approved, Investigational Phase 3,Phase 2 6055-19-2, 50-18-0 2907
8
Vincristine Approved, Investigational Phase 3,Phase 2 57-22-7, 2068-78-2 5978
9
Epirubicin Approved Phase 3,Phase 2 56420-45-2 41867
10
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
11
Isophosphamide mustard Phase 3,Phase 2 0
12 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
13 Antineoplastic Agents, Alkylating Phase 3,Phase 2
14 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
15 Alkylating Agents Phase 3,Phase 2
16 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
17 Antineoplastic Agents, Phytogenic Phase 3,Phase 2
18 Immunologic Factors Phase 3,Phase 2
19 Anti-Infective Agents Phase 3,Phase 2
20 Etoposide phosphate Phase 3,Phase 2
21 Antimitotic Agents Phase 3,Phase 2
22 Antirheumatic Agents Phase 3,Phase 2,Phase 1
23 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
24 Immunosuppressive Agents Phase 3,Phase 2
25
Lenograstim Approved, Investigational Phase 2 135968-09-1
26
Celecoxib Approved, Investigational Phase 1 169590-42-5 2662
27 Anti-Inflammatory Agents, Non-Steroidal Phase 1
28 Cyclooxygenase 2 Inhibitors Phase 1
29 Cyclooxygenase Inhibitors Phase 1
30 Analgesics, Non-Narcotic Phase 1
31 Peripheral Nervous System Agents Phase 1
32 Analgesics Phase 1
33 Anti-Inflammatory Agents Phase 1
34 Antibodies, Monoclonal Phase 1
35 Immunoglobulins Phase 1
36 Antibodies Phase 1

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Unknown status NCT00334854 Phase 3 doxorubicin hydrochloride;ifosfamide
2 Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00002898 Phase 3 carboplatin;cyclophosphamide;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
3 Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors Completed NCT00025441 Phase 2 carboplatin;cyclophosphamide;doxorubicin hydrochloride;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
4 Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery Completed NCT00450736 Phase 1 celecoxib
5 Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Completed NCT00720174 Phase 1 Doxorubicin Hydrochloride

Search NIH Clinical Center for Childhood Malignant Hemangiopericytoma

Genetic Tests for Childhood Malignant Hemangiopericytoma

Anatomical Context for Childhood Malignant Hemangiopericytoma

Publications for Childhood Malignant Hemangiopericytoma

Variations for Childhood Malignant Hemangiopericytoma

Expression for Childhood Malignant Hemangiopericytoma

Search GEO for disease gene expression data for Childhood Malignant Hemangiopericytoma.

Pathways for Childhood Malignant Hemangiopericytoma

GO Terms for Childhood Malignant Hemangiopericytoma

Sources for Childhood Malignant Hemangiopericytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....